Featured Research

Atomized Intranasal Dexmedetomidine Shows Promise as Pediatric Sedative Atomized intranasal dexmedetomidine has proven to be an effective sedation drug, but its pharmacokinetics have previously only been studied in adults. Its potential value during diagnostic procedures in children, with the inherent advantage of not requiring vascular access, was unknown. The risk of instability in heart rate caused by dexmedetomidine is challenging in the pediatric landscape, particularly in infants and toddlers.